Ortho Evra
Home 
Practice Areas Pharmaceutical Liability Ortho Evra
Since its arrival to the market in 2002, the Ortho Evra birth control patch has been the subject of twenty one reports of life-threatening blood clots in the women who have used the product. Manufactured by Johnson and Johnson, the popular contraceptive patch became the subject of an FDA warning when on November 10, 2005, the agency warned that the birth control patch contains higher levels of estrogen, a hormone known to cause an increased risk of blood clots, a risk greater than that found in the more traditional birth control preparations. As a result, the manufacturer has changed its labeling to now reflect that use of the Ortho Evra patch exposes young women to 60 percent more estrogen than those who use a typical pill,— and consequently subjects them to a greater risk of adverse clots and other events.
Since its entry in the marketplace, nearly 4 million women have used the patch, which has also been linked to the deaths of at least seventeen women who suffered fatal heart attacks, blood clots and possible strokes over the past two years. Ortho-McNeil, a subsidiary of Johnson & Johnson and the manufacturer of Ortho Evra, has aggressively marketed the birth control patch as a convenient alternative to oral birth control pills.
Ashkin Law Firm
580 Broadway Suite 906
New York, New York 10012
Office: 212 -965-0010
Fax: 212 -965-1301
» click here to locate our office